Inventors:
John Donnelly - Moraga CA, US
Margaret Liu - Lafayette CA, US
John Shiver - Chalfont PA, US
Tong-Ming Fu - Ambler PA, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C12Q001/70, C07H021/04, C12N007/01, C07K014/02, C12N015/86
US Classification:
435005000, 435069300, 435235100, 435456000, 435325000, 530350000, 536023720
Abstract:
This invention relates to novel formulations of pharmaceutical products, specifically nucleic acid vaccine products. The nucleic acid vaccine products, when introduced directly into muscle cells, induce the production of immune responses which specifically recognize Hepatitis C virus (HCV).